About us

Chongqing Huapont Pharmaceutical Co., Ltd. (abbreviated to Huapont Pharm. hereafter) is a leading dermatological drug manufacturer in China. Huapont Pharm., founded in 1992 by Dr. Songshan Zhang, is now a group member of Huapont Life Science Co., Ltd. the latter is a non-state owned public company listed in Shenzhen Stock Exchange since 2004.

With over 20 years’ development, Huapont Pharm. continuously provides the highly effective medicines and services to patients and society by relying on science and technology. From a leading manufacturer of dermatological drugs, Huapont Pharm. gradually expands the product coverage to respiratory system drugs, anti-tumors drugs, antituberculosis drugs and cardio-cerebrovascular drugs, etc. Both the finished dosage forms (FDFs) and active pharmaceutical ingredients (APIs) are manufactured and supplied to the domestic and international market.

The API facility of Huapont Pharm. has become an exporting base of APIs, with GMP status inspected and approved by end-users as well as regulatory authorities such as US-FDA, MEDSAFE, COFEPRIS.

HUAPONT is a leading manufacturer of dermatological drugs and gradually expand the product mix to respiratorysystem drugs, drugs for tumors, drugs treating cardio-cerebrovascular diseases, etc. Both the inished dosage forms (FDFs) and active pharmaceuticalingredients (APIs) are manufactured and supplied to the domestic and international market.

APIs supplied by HUAPONT. The API facility of HUAPONT has become an exporting base of APIs, where ofGMP has inspected and approved by US-FDA, Medsafe, COFEPRIS, other countries authorities and number of customers. Furthermore HUAPONT is the top three of dermatological drug manufacturer in China. It is proud that many generic pharmaceutical companies of worldwide are relying on APIs supplied by HUAPONT.